Caligan Partners »

Sellas Life Sciences Group I shares owned by Caligan Partners

Quarter-by-quarter ownership of Sellas Life Sciences Group I (SLS) shares owned by Caligan Partners from 13F filings

Historical chart of Caligan Partners investment in Sellas Life Sciences Group I

Tip: Access up to 7 years of quarterly data

All positions including Sellas Life Sciences Group I held by Caligan Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sellas Life Sciences Group I by Caligan Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $3.7M 2.3M 1.61
2025-06-30 $5.0M 2.3M 2.19

More positions owned by Caligan Partners

Liquidia Corporation Com New (LQDA)
Abivax Sa Sponsored Ads (ABVX)
Mineralys Therapeutics (MLYS)
Agios Pharmaceuticals (AGIO)
Exelixis (EXEL)
Revolution Medicines (RVMD)
Adma Biologics (ADMA)
Evolus (EOLS)
Merus N V (MRUS)
Xenon Pharmaceuticals (XENE)
Anika Therapeutics (ANIK)
Avalo Therapeutics Com New (AVTX)
Tyra Biosciences (TYRA)
Inhibrx Biosciences (INBX)
Verrica Pharmaceuticals Com Shs (VRCA)

View all positions for Caligan Partners

Top funds holding Sellas Life Sciences Group I

Vanguard Group
Frigate Ventures
BlackRock
Susquehanna International
Marshall Wace
Caligan Partners
Geode Capital Management
State Street Corporation
Nuveen
Citadel Advisors
Northern Trust
Dagco
GSA Capital Partners
Everhart Financial Group
Diadema Partners

View all funds holding Sellas Life Sciences Group I